POSTER SESSION IV
Tuesday, March 1, 2011 — 1:00 PM - 4:30 PM
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
PULMONARY PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
246
Increased Caspase-9 Gene Expression Contrast with Normal Type V Collagen and VEGF Isoforms Gene Expression in Lung Chemical Carcinogenesis.
(1791)
ER Parra, RA Alveno, CB Faustino, PYSS Correa, J de Morais, WR Teodoro, VL Capelozzi - Faculdade de Medicina da Universidade de Sao Paulo, Brazil
miR-205 and miR-21 Quantification in Adenocarcinomas and Squamous Cell Carcinoma of the Lung.
(1734)
V Del Vescovo, C Cantaloni, A Cucino, S Girlando, M Silvestri, E Bragantini, L Morelli, S Fasanella, LV Cuorvo, P Dalla Palma, G Rossi, M Papotti, G Pelosi, P Graziano, A Cavazza, MA Denti, M Barbareschi - University of Trento, Italy; S.Chiara Hospital, Trento, Italy; S. Chiara Hospital, Trento, Italy; Azienda Ospedaliera-Universitaria Policlinico, Modena, Italy; San Luigi Hospital and University of Turin, Orbassano, Italy; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Forlanini Hospital, Rome, Italy; Arcispedale S. Maria Nuova, Reggio Emilia, Italy
Expression and Diagnostic Implication of HPV and p16 in Squamous Cell Carcinoma in Multiple Organ Sites.
(1722)
O Asojo, K Wikenheiser-Brokamp, G Hill, F Lucas, C Hackett, QJ Zhai - Univ. of Cincinnati, OH
HuR Involvement in PTHrP Expression in Human Lung Adenocarcinoma.
(1772)
L Lauriola, G Monego, P Lanza, M Novello, FO Ranelletti - Catholic University, Rome, Italy
EZH2 Expression Is Correlated with Histologic Grade of Lung Adenocarcinoma.
(1741)
JJ Findeis-Hosey, LA McMahon, Q Yang, F Li, H Xu - University of Rochester, NY
EZH2 Expression in Invasive Squamous Cell Carcinoma of the Lung and Its Precursor Lesions.
(1742)
JJ Findeis-Hosey, LA McMahon, Q Yang, F Li, H Xu - University of Rochester, NY
Expression and Clinical Significance of Prohibitin in Primary Lung Squamous Cell Carcinoma.
(1748)
F Guo, K Hiroshima, T Tomonaga, F Nomura, O Matsubara, Y Nakatani - Chiba University Graduate School of Medicine, Japan; Tokyo Women's Medical University Yachiyo Medical Center, Chiba, Japan; National Institute of Biomedical Innovation, Osaka, Japan; National Defense Medical College, Tokorozawa, Japan
Presence and Absence of Chondroitin Sulfate in Lung Tissues as a Potential Diagnostic Marker of Lung Cancer.
(1794)
M Peres Rangel, JR Maciel Martins, VK de Sa, ER Parra Cuentas, E Olivieri, VL Capelozzi - Faculdade de Medicina da Universidade de Sao Paulo, Brazil; Universidade Federal de Sao Paulo, Sao Paulo, Brazil; Hospital A.C. Camargo, Sao Paulo, Brazil
Expression of SOX2 and p63 Do Not Have Independent Prognostic Significance in Stage I Lung Adenocarcinoma.
(1770)
AE Kovach, EJ Mark, M Mino-Kenudson - Massachusetts General Hospital, Boston
Sonic Hedgehog (Shh) Pathway Signaling and Clinical Outcome in Non Small Cell Lung Cancers (NSCLC).
(1773)
L Li, W Mneimneh, CE Sheehan, JS Ross - Albany Medical College, NY
Prognostic Significance of Aurora A Kinase (AURKA) Expression in Non Small Cell Lung Cancer (NSCLC).
(1774)
L Li, CE Sheehan, JS Ross - Albany Medical College, NY
c-Met Amplification and Protein Expression in Non-Small Cell Lung Cancers.
(1812)
K Tsuta, A Yoshida, H Tsuda - National Cancer Center Hospital, Tsukiji, Tokyo, Japan
Association of c-Met Activation with Micropapillary Pattern and Small Cluster Invasion in pT1 Lung Adenocarcinoma.
(1769)
K Koga, M Hamasaki, F Kato, H Hayashi, A Iwasaki, H Kataoka, K Nabeshima - Fukuoka University Hospital and School of Medicine, Japan; Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
Immunohistochemical Analysis of ALK Fusion-Positive Lung Cancers: Correlation with FISH, Molecular Findings and Morphology.
(1799)
ST Saab, C Lovly, CJ Hollis, Y Ashwini, H Ji, W Pao, A Gonzalez - Vanderbilt University, Nashville, TN; Chinese Academy of Sciences, Shanghai, China
Comparison of IHC, FISH and RT-PCR for the Detection of EML4-ALK Translocation Variants in Non-Small Cell Lung Cancer.
(1814)
ML Wallander, KB Geiersbach, S Tripp, LJ Layfield - ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT; University of Utah School of Medicine and ARUP Laboratories, Salt Lake City
Most ALK-Positive Lung Adenocarcinomas Exhibit Characteristic Histology.
(1824)
A Yoshida, K Tsuta, T Kohno, M Fukayama, T Shibata, K Furuta, H Tsuda - National Cancer Center Hospital, Tokyo, Japan; National Cancer Center Research Institute, Tokyo, Japan; University of Tokyo, Japan
Histologic and Cytomorphologic Features of ALK-Rearranged Lung Adenocarcinomas.
(1787)
M Nishino, VE Klepeis, K Bergethon, EJ Mark, AJ Iafrate, M Mino-Kenudson - Massachusetts General Hospital, Boston
Determining Percent EGFR Activation in Tumor Cells in Intact FFPE Tissue Sections.
(1754)
C Hoyt, K Lane, G Innocenti, R Wetzel - Cambridge Research and Instrumentation, Inc., Woburn, MA; Cell Signaling Technology, Danvers, MA
High Expression of Folate Receptor Alpha in Lung Cancer Correlates with Adenocarcinoma Histology and EGFR Mutation.
(1788)
MI Nunez, C Behrens, DM Woods, H Lin, M Suraokar, H Kadara, JD Minna, W Hofstetter, N Kalhor, WK Hong, JJ Lee, W Franklin, D Stewart, II Wistuba - MD Anderson Cancer Center, Houston, TX; The University of Texas Southwestern Medical Center, Dallas; University of Colorado, Denver
The Predictive Value of EGFR/KRAS/BRAF Genotyping and TP53 Expression in a Series of 54 Patients with Lung Adenocarcinoma Treated with Tyrosine Kinase Inhibitors.
(1753)
S Houlle, A Perel, F Blanchard, A Lamy, P Courville, L Thiberville, J-C Sabourin - Rouen University Hospital, France
EGFR Mutations in Exons 18, 19 and 21 Are Closely Associated with TTF-1 Positive Lung Adenocarcinoma.
(1749)
M Guo, Q Si, Y Gong, N Kalhor, S Chen, C Moran - The Univerisity of Texas M.D. Anderson Cancer Center, Houton
Lung Adenocarcinoma in Young Adults: EGFR/KRAS/ALK Mutation Status and Clinicopathological Features in 64 Patients under Age 40.
(1735)
S Dogan, SC Jhanwar, M Ladanyi, MF Zakowski - Memorial Sloan-Kettering Cancer Center, New York, NY
Lung Carcinomas in Young Patients: A Clinicopathologic and Immunohistochemical Assessment of 140 Cases.
(1819)
RL Woodford, AS Nagji, DR Jones, EB Stelow - University of Virginia, Charlottesville
Prognostic Factors for Stage I Non Small Cell Lung Cancer: A Single Institution Experience.
(1744)
F Franzi, A Imperatori, N Rotolo, L Dominioni, C Capella, F Sessa - University of Insubria, Varese, Italy; Multimedica IRCCS, Milan, Italy
Clinicopathological Characteristics of Subcentimeter Adenocarcinomas of the Lung.
(1763)
F Kato, M Hamasaki, A Iwasaki, H Iwasaki, K Nabeshima - Fukuoka University Hospital and School of Medicine, Japan
Assessing the Pleura and Other Objective and Routine Findings Predicting Outcome with Stage 1 Non-Small Cell Lung Carcinoma.
(1758)
SK Jeffus, AS Nagji, BD Kozower, DR Jones, EB Stelow - University of Virginia, Charlottesville
Nuclear Grading System Predicts Recurrence in Stage I Lung Adenocarcinoma Patients.
(1759)
K Kadota, K Suzuki, VW Rusch, AL Moreira, PS Adusumilli, WD Travis - Memorial Sloan-Kettering Cancer Center, New York, NY; Memorial Sloan-Kettering, Cancer Center, New York, NY
Validation of the IASLC/ATS/ERS Lung Adenocarcinoma (ADC) Classification and Use of Comprehensive Histologic Subtyping (CHS) for Architectural Grading in 432 Japanese Patients.
(1825)
A Yoshizawa, S Sumiyoshi, AL Moreira, WD Travis - Kyoto University Hospital, Japan; Memorial Sloan-Kettering Cancer Center, New York
The Significance of Minimally Invasive Adenocarcinoma in the Classification of Pulmonary Tumors.
(1821)
LF Xu, R Battafarano, W Burrows, AP Burke - University of Maryland, Baltimore; Uninversity of Maryland, Baltimore
Are Bronchioloalveolar Carcinoma and Early Invasive Adenocarcinoma More Frequent in Elderly Caucasians Than in Young Asian Women?
(1815)
AE Walts, A Riley-Portuges, A Pao, T Truong, L Baden, J Lopategui, AM Marchevsky - Cedars-Sinai Medical Center, Los Angeles, CA
Root Cause Analysis of Problems in Frozen Section Diagnosis of Bronchioloalveolar Carcinoma and Early Invasive Adenocarcinoma of the Lung.
(1777)
AM Marchevsky, RJ McKenna, AE Walts - Cedars-Sinai Medical Center, Los Angeles, CA
Limited Impact of Distinguishing between Bronchioloalveolar Carcinoma and Early Invasive Adenocarcinoma of the Lung in Frozen Sections.
(1817)
AE Walts, RJ McKenna, AM Marchevsky - Cedars-Sinai Medical Center, Los Angeles, CA
Biopsy Site Changes in Lung Carcinomas Following Core Needle Biopsy: A Potential Pitfall in the Assessment of Stromal Invasion.
(1737)
EE Doxtader, S Mukhopadhyay, A-L Katzenstein - State University of New York Upstate Medical University, Syracuse
Nonsmall Cell Lung Carcinoma (NSCLC), Not Otherwise Specified (NOS) Diagnosed by Fine Needle Aspiration Biopsy (FNAB): Reviewed with Attempt To Reclassify with a Specific Diagnosis, Based on Classic Cytomorphological Features (CCMF).
(1732)
CL Cookingham, K Montoya, KR Geisinger - Wake Forest University Health Science, Winston Salem, NC
Evaluation of Cyto-Histologic Agreement for Defining Histologic Subtype of Lung Carcinoma.
(1771)
SW Lai, MA Saieg, WR Geddie, SL Boerner, GC Santos - University Health Network, Toronto, ON, Canada; University of Toronto, ON, Canada
Utility of Ancillary Studies in the Classification of Lung Adenocarcinoma and Squamous Cell Carcinoma in Cytology Specimens.
(1789)
R Ocque, N Tochigi, P Ohori, S Dacic - University of Pittsburgh Medical Center, PA
Common Markers (Cytokeratins 5/6&7, p63, TTF1, Vimentin) on Small Biopsies of Non-Small Cell Lung Cancer Effectively Parallel Profiling and Eventual Diagnoses of Surgical Specimens.
(1793)
G Pelosi, M Papotti, G Rossi, A Sonzogni - National Cancer Institute, Milan, Italy; San Luigi Hospital and University of Turin, Orbassano, Italy; Azienda Ospedaliera-Universitaria Policlinico, Modena, Italy; European Institute of Oncology, Milan, Italy
Performance of Cytologic Specimens in EGFR and KRAS Molecular Testing with a Focus on Minimal Cellularity Requirements.
(1726)
SM Brandt, LJ Tafe, ME Arcila, AL Moreira, MF Zakowski, M Ladanyi, N Rekhtman - Weill Cornell Medical College, New York, NY; Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY
High-Resolution Volumetric Imaging of Lung Pathology: Improving Biopsy Sampling and Evaluation.
(1751)
LP Hariri, M Mino-Kenudsen, EJ Mark, MB Applegate, GJ Tearney, BE Bouma, MJ Suter - Massachusetts General Hospital, Boston
Intrapulmonary Solitary Fibrous Tumors . A Clinicopathologic Analysis of 25 Cases.
(1795)
N Rao, G Falconieri, C Moran, T Colby, H Cohen, S Suster - Medical College of Wisconsin, Milwaukee; MD Anderson Cancer Center, Houston, TX; Mayo Clinic, Scottsdale, AZ; S. Maria della Misericordia General Hospital, Udine, Italy; Western Galilee Hospital, Naharia, Israel
button next to any title to add to Itinerary Planner...
Add
